SCHEMBL7230635

SCHEMBL7230635

COc1ccnc(-c2cc(N)cc(N)c2C)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.56
CCR5 P51681 1/20 0.56
CCR8 P51685 1/20 0.56
NOS3 P29474 2/20 0.49
NOS1 P29475 2/20 0.49
NOS2 P35228 2/20 0.49
PLAU P00749 1/20 0.42
KDM4C Q9H3R0 1/20 0.40
DYRK1A Q13627 4/20 0.36
CYP3A4 P08684 3/20 0.36
ALDH1A1 P00352 3/20 0.36
GSK3B P49841 2/20 0.36
MAP3K14 Q99558 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
CYP2C19 P33261 1/20 0.35
CBFB Q13951 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7239732 0.80 CCR1 (0.58) CCR1CCR5CCR8NOS3NOS1
SCHEMBL7844941 0.76 CCR1 (0.61) CCR1CCR5CCR8NOS3NOS1
SCHEMBL2651772 0.76 CCR1 (0.56) CCR1CCR5CCR8NOS3NOS1
SCHEMBL29395249 0.74 CCR1 (1.00) CCR1CCR5CCR8NOS3NOS1
SCHEMBL182529 0.74 CCR1 (1.00) CCR1CCR5CCR8NOS3NOS1
Methane SCHEMBL21386924 0.72 CCR1 (0.95) CCR1CCR5CCR8NOS3NOS1
Hydrochloric Acid SCHEMBL29903189 0.72 CCR1 (0.95) CCR1CCR5CCR8NOS3NOS1
SCHEMBL8746042 0.72 CCR1 (0.95) CCR1CCR5CCR8NOS3NOS1
SCHEMBL9135460 0.72 CCR1 (0.95) CCR1CCR5CCR8NOS3NOS1
SCHEMBL28212407 0.72 CCR1 (0.95) CCR1CCR5CCR8NOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6521643-B1 Prevention and/or treatment of nitric oxide synthasey medi-ated diseases such as adult respiratory distress syndrome, myocarditis, synovitis, septic shock, diabetes, ulcerative colitis, cerebral infarction, osteoarthritis FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-02-18 US disclosed
EP-1157022-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-28 EP disclosed
WO-2000049015-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-24 WO disclosed